BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 16520805)

  • 1. Cancer-related anemia and recombinant human erythropoietin--an updated overview.
    Bohlius J; Weingart O; Trelle S; Engert A
    Nat Clin Pract Oncol; 2006 Mar; 3(3):152-64. PubMed ID: 16520805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risks and benefits of erythropoiesis-stimulating agents in cancer management.
    Beutel G; Ganser A
    Semin Hematol; 2007 Jul; 44(3):157-65. PubMed ID: 17631180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant human erythropoietin in cancer-related anemia. Review of clinical evidence.
    Crawford J
    Oncology (Williston Park); 2002 Sep; 16(9 Suppl 10):41-53. PubMed ID: 12380954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epoetins and [symbol: see text] darbepoetin alfa in malignant disease.
    Drug Ther Bull; 2004 Mar; 42(3):21-3. PubMed ID: 15038080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2007 Standards, Options, and Recommendations: use of erythropoiesis-stimulating agents (ESA: epoetin alfa, epoetin beta, and darbepoetin) for the management of anemia in children with cancer.
    Marec-Berard P; Chastagner P; Kassab-Chahmi D; Casadevall N; Marchal C; Misset JL; Ray-Coquard I
    Pediatr Blood Cancer; 2009 Jul; 53(1):7-12. PubMed ID: 19229970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The blue cross blue shield assessment technology review: summary of findings.
    Bennett CL
    Best Pract Res Clin Haematol; 2005; 18(3):423-31. PubMed ID: 15792916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of recombinant human erythropoietin (rHuEPO) on tumor control in patients with cancer-induced anemia.
    Vaupel P; Dunst J; Engert A; Fandrey J; Feyer P; Freund M; Jelkmann W
    Onkologie; 2005 Apr; 28(4):216-21. PubMed ID: 15840971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase III clinical trials with darbepoetin: implications for clinicians.
    Glaspy J
    Best Pract Res Clin Haematol; 2005; 18(3):407-16. PubMed ID: 15792914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical application of recombinant erythropoietin in anemic cancer patients.
    Henry DH
    Hematol Oncol Clin North Am; 1994 Oct; 8(5):961-73. PubMed ID: 7852218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anemia, tumor hypoxemia, and the cancer patient.
    Varlotto J; Stevenson MA
    Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):25-36. PubMed ID: 16111569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant human erythropoietin treatment of anemic cancer patients.
    Henry DH
    Cancer Pract; 1996; 4(4):180-4. PubMed ID: 8900758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EPO in cancer anemia: benefits and potential risks.
    Milano M; Schneider M
    Crit Rev Oncol Hematol; 2007 May; 62(2):119-25. PubMed ID: 17197190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anemia in lung cancer: clinical impact and management.
    Pirker R; Wiesenberger K; Pohl G; Minar W
    Clin Lung Cancer; 2003 Sep; 5(2):90-7. PubMed ID: 14596691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The ASH/ASCO clinical guidelines on the use of erythropoietin.
    Lichtin A
    Best Pract Res Clin Haematol; 2005; 18(3):433-8. PubMed ID: 15792917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erythropoietic therapy for the treatment of anemia in patients with cancer: a valuable clinical and economic option.
    Cornes P; Coiffier B; Zambrowski JJ
    Curr Med Res Opin; 2007 Feb; 23(2):357-68. PubMed ID: 17288690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Practitioners' practical model for managing cancer-related anemia.
    Smith RE; Tchekmedyian S
    Oncology (Williston Park); 2002 Sep; 16(9 Suppl 10):55-63. PubMed ID: 12380955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Darbepoetin alfa for the treatment of cancer-related anemia: an update.
    Pirker R
    Expert Rev Anticancer Ther; 2004 Oct; 4(5):735-44. PubMed ID: 15485310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of cancer-related anemia.
    Badzek S; Curić Z; Krajina Z; Plestina S; Golubić-Cepulić B; Radman I
    Coll Antropol; 2008 Jun; 32(2):615-22. PubMed ID: 18756919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Standard of care for cancer-related anemia: improving hemoglobin levels and quality of life.
    Cortesi E; Gascón P; Henry D; Littlewood T; Milroy R; Pronzato P; Reinhardt U; Shasha D; Thatcher N; Wilkinson P
    Oncology; 2005; 68 Suppl 1():22-32. PubMed ID: 15855813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythropoietin in cancer-related anemia.
    Fenner MH; Ganser A
    Curr Opin Oncol; 2008 Nov; 20(6):685-9. PubMed ID: 18841051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.